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Poster Session-II 135Follow up for infections was censored at time of relapse or death.
Hazard ratios (HR) of outcome of patients with above vs below me-
dian immune subset count at the beginning of each interval were de-
termined. The HR was adjusted for disease stage, stem cell source,
immunosuppressive therapy for GVHD, and use of antimicrobial
prophylaxis. Due to multiple comparisons, HR was considered sig-
nificant only if p\0.01.
Results:No association was found between an immune cell subset
count and fatal infection, non-relapse mortality, survival, or relapse.
Regarding infections, the only significant association between a day
30 subset count and day 30–80 infections was betweenCD4-CD8-T
cells and viral infections. For the subsequent time intervals, conspic-
uous associations are shown in Table 1.
Immune cell subset above the median and hazard ratio of
definite and bacterial infections
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Conclusion: In contrast to previous studies, no association was
found between an immune cell subset count and fatal infection,
non-relapse mortality, survival, or relapse. Associations between
some immune cell subset counts and infections exist and should be
further studied.377
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Viral infections (CMV, EBV and Adenovirus) can be fatal compli-
cations post allogeneic hematopoietic stem cell and solid organ
transplantation. Administration of virus-specific CTLs, targeting in-
dividual- or multiple-viral antigens is effective in these patients.
However, in those whose immunosuppressive treatment needs to
be maintained to prevent GvHD or organ rejection, expansion and
persistence of adoptively transferred virus-specific CTLs are im-
paired. FK506 is frequently used as immunosuppressive drug. Its ef-
fects depend on binding to FKBP12 proteins. SinceT cells generated
from FKBP12 knockout mice are resistant to the inhibitory effects of
FK506, we knocked down FKBP12 using a small interfering RNA
(siRNA) to generate virus- specific CTLs resistant to FK506. As
a model we used EBV1 tumor and EBV-CTLs. We identified one
siRNA sequence (siRNA4), that knocked down .90% of FKBP12
expression in T cell lines and virus-CTLs. We then generated 2 ret-
roviral vectors encoding for siRNA4/eGFP and irrelevant siRNA/
eGFP and used them to transduce CTLs generated from 7 EBV-
seropositive donors. Transduction efficiency was 46 6 22% for
siRNA4 and 556 27% for irrel.-siRNA. We measured the prolifer-
ation of transduced CTLs in the presence of FK506, in short and
long term cultures. We found that in the presence of FK506, prolif-
eration of control CTLs was significantly inhibited (by 746 2%) as
compared to siRNA41 CTLs (41 6 4%). In long term cultures,modified CTLs were stimulated weekly with EBV1 cells, with or
without FK506 (5ng/ml) and low dose IL-2 (20U/mL). The propor-
tion of siRNA41CTLs increased over time not only as a percentage
of GFP1 cells (from 466 22% to 896 5% after 5 stimulations) but
also numerically (34median fold expansion, range 5–60). In contrast,
control CTLs did not show any selection in culture, as the percent-
age of GFP1 cells remained unchanged (from 56 6 27% to 57 6
23%) and CTLs ceased to proliferate (2 median fold expansion,
range 0–5). Finally, we found that siRNA41 CTLs retained their
MHC-restricted cytotoxicity against EBV1 cells (66 6 22% lysis
at an E:T ratio of 20:1). Modified CTLs also maintained their pro-
duction of IFN-g in response to EBV-peptides, as assessed by ELI-
spot assays. In conclusion, we have developed a strategy that
produces virus-specific CTLs resistant to FK506. This strategy
may be beneficial to improve virus immune reconstitution in patients
post transplant, despite ongoing immunosuppresion.378
ASSOCIATION BETWEEN HLA-E POLYMORPHISM AND SEVERE FUNGAL
INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
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HLA-E is a non classical HLA class I molecule that interacts with
NK cell CD94/NKG2 family receptors as a major ligand playing
a dual role in NK cell modulation and T cell activation, either inhib-
iting or triggering the citotoxicity by these cells. These roles indicate
the involvement of HLA-E antigen in host-immune response against
pathogens. The aim of this studywas to evaluate whether theHLA-E
alleles have functional impact on the incidence of bacterial, viral and
fungal infections in patients who have undergone an HLA identical
sibling myeloablative hematopoietic stem cell transplantation
(HSCT). One hundred and seven patients and their respective do-
nors were included in this study. HSCT was performed from 1999
to 2006, with a minimum of 6 months follow up. The distinction be-
tween HLA-E*0101 and HLA-E*0103 alleles was done either by
polymerase chain reaction – restriction fragment length polymor-
phism (PCR-RFLP) and polymerase chain reaction – sequence spe-
cific primer (PCR-SSP). The predictive effect of HLA-E genotype
(HLA-E* 0101/ E*0101, E* 0101/E* 0103 and E*0103/ E*0103)
was assessed as variables.Univariate analysis using death as a compet-
ing risk were done to evaluate the association between HLA-E poly-
morphism with first infections episodes. HLA-E genotype showed
no association with severe bacterial infection or viral infections.
However, in first severe fungal infection episode HLA-E* 0101/
E*0101 genotype was found to have a protective effect (P 5 0.01),
since none of the patients who had severe fungal infections had
this haplotype. In conclusion, it is possible that HLA-E genotype
polymorphism fulfills a related function to fungal infection after
HSCT, although these are preliminary data and need further
confirmation.379
A ROLE FOR IRAK-M IN PGE2-INDUCED IMMUNOSUPPRESSION POST-
BONE MARROW TRANSPLANT
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Rationale: Following bone marrow (BM) transplantation (BMT),
patients are susceptible to lung infections. In a mouse model of syn-
geneic BMT, we have shown BMT alveolar macrophages (AMs) and
alveolar epithelial cells (AECs) overproduce prostaglandin E2
(PGE2) relative to non-transplant controls. Overproduction of
PGE2 significantly impairs neutrophil killing and inhibits both
phagocytosis and killing in AMs. These defects are also associated
with diminished TNF-alpha production. However, a mechanism
by which PGE2 overproduction suppresses lung innate immune
cell function post-BMT is unknown. As interleukin-1 receptor asso-
ciated kinase (IRAK)-M is a known inhibitor of MyD88-dependent-
